Correlation Between Mereo BioPharma and Pyxis Oncology
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Pyxis Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Pyxis Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Pyxis Oncology, you can compare the effects of market volatilities on Mereo BioPharma and Pyxis Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Pyxis Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Pyxis Oncology.
Diversification Opportunities for Mereo BioPharma and Pyxis Oncology
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Mereo and Pyxis is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Pyxis Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pyxis Oncology and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Pyxis Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pyxis Oncology has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Pyxis Oncology go up and down completely randomly.
Pair Corralation between Mereo BioPharma and Pyxis Oncology
Given the investment horizon of 90 days Mereo BioPharma Group is expected to generate 0.36 times more return on investment than Pyxis Oncology. However, Mereo BioPharma Group is 2.79 times less risky than Pyxis Oncology. It trades about -0.24 of its potential returns per unit of risk. Pyxis Oncology is currently generating about -0.23 per unit of risk. If you would invest 420.00 in Mereo BioPharma Group on August 28, 2024 and sell it today you would lose (82.00) from holding Mereo BioPharma Group or give up 19.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mereo BioPharma Group vs. Pyxis Oncology
Performance |
| Timeline |
| Mereo BioPharma Group |
| Pyxis Oncology |
Mereo BioPharma and Pyxis Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mereo BioPharma and Pyxis Oncology
The main advantage of trading using opposite Mereo BioPharma and Pyxis Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Pyxis Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pyxis Oncology will offset losses from the drop in Pyxis Oncology's long position.| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
| Pyxis Oncology vs. Zura Bio Limited | Pyxis Oncology vs. Altamira Therapeutics | Pyxis Oncology vs. Elevation Oncology | Pyxis Oncology vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |